Searched for
ICLINIC
Japanese biotech developing tooth-regrowing drug raises $5.3 million to advance human trialsToregem BioPharma has secured $5.3 million to advance its experimental tooth-regeneration drug, TRG035, into Phase II clinical trials. The ...- Novartis sharpening India strategy as a pure-play innovatorNovartis India country president and managing director Amitabh Dube said India is gradually moving beyond its traditional role as a clinica...
- 2nd T20I: Clinical India aim to seal series against West IndiesAfter being outclassed 0-3 in the ODI leg in Ahmedabad, the Kieron Pollard-led team was expected to give India some challenge in its favour...
- DCGI nod to phase-I clinical trial of COVID-19 vaccine of Reliance Life SciencesThe firm is required to submit the revised clinical trial protocol for immunogenicity to be assessed on Day 42, instead of Day 14, as recom...
- Intranasal COVID vaccine candidate in early clinical stage of development in India: GovtMost vaccines are administered by injection through intramuscular or subcutaneous route.
- Reported adverse event during Covaxin phase 1 trial within 24 hours: Bharat BiotechThe statement was issued following a report by Economic Times which revealed that a serious adverse event was seen in a case during the Pha...
- IAVI, Merck KGaA, Serum Institute join hands to develop monoclonal antibodies for Covid-19A phase-I clinical trial is expected to start in early 2021.
- Zydus Cadila to commence phase II clinical trials of COVID-19 vaccine ZyCoV-D from Aug 6"The company reports that the doses of the vaccine administered to healthy volunteers in the phase I clinical trial, which began on July 15...
- How Vodafone, like Unilever or McKinsey, has turned into the new laboratory of CXO talentAs the world’s largest telecom company unwinds its India presence after agreeing to merge its operations with Idea Cellular, it leaves behi...
- Glenmark Pharmaceuticals completes phase I clinical trials for antibodyGlenmark Pharmaceuticals has completed the clinical phase I studies for its novel monoclonal antibody 'GBR 830' for treating autoimmune dis...
- Ravi Jaipuria's RJ Corp buys health startup iClinic; Diagno to be merged with itiClinic, which has a clutch of investors besides Mukerji and Berry, was set up in 2012 with the business model of offering healthcare to pe...
- Healthcare startups tying up funds to increase footprintTechnology-enabled models, like iClinic & iKure, are emerging in India which are addressing lack of healthcare facilities in underserved re...
- Executives quitting cushy jobs at big firms in exchange for challenging assignments in startups“Unlike MNCs which have pre-defined roles, the challenges, the sense of ownership and the work culture in a start-up is more fulfilling."
- Glenmark Pharmaceuticals's monoclonal antibody for pain entering human trialsGBR 900 is a monoclonal antibody for the treatment of chronic pain targeting TrkA, the receptor of nerve growth factor (NGF).
- ET Profile: Varun Berry loving new challenge as Britannia's head of India operationsBerry has flung himself at this job with characteristic gusto. "I am a dreamer," he says. "When I fail, at times, to achieve those dreams, ...
- Queppelin's right ‘App’titude for enterprisesQueppelin is attempting to be the mobile application partner and consultant to enterprises large and small.
- Govt not to allow trials for drugs developed outside IndiaThe health ministry will put on hold its plans to grant permissions to multinational pharma firms for conducting phase I clinical trials of...
- Glenmark to start phase I clinical trials of GBR 500 in USDrug firm Glenmark pharmaceuticals on Friday said it will file an application with American health regulator US Food and Drug Administrator...
- Suven starts phase I clinical trials of SUVN-502Pharmaceutical firm Suven Life Sciences today said it has commenced phase I clinical trials of SUVN-502, used in the treatment of Alzheimer...
- Glenmark eyes pain management marketGlenmark Pharmaceuticals on Monday said its Swiss subsidiary has completed phase I clinical trials for GRC 6211, a pain reliever, and plans...
Load More
